FROM:
Int J Immunopharmacol 1997 (Jul); 19(7): 371–9
Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG
Nutri-Pro LC, Salt Lake City, Utah, USA
Echinacea purpurea, a plant originally used by native Americans
to treat respiratory infections, was evaluated for its ability to
stimulate the production of cytokines by normal human peripheral
blood macrophages in vitro. Commercial preparations of echinacea
fresh pressed juice and dried juice were tested at concentrations
ranging from 10 g/ml to 0.012 g/ml and compared to endotoxin
stimulated and unstimulated controls. Cytokine production was
measured by ELISA after 18 h of incubation for IL-1 and 36 and 72
h for TNF-x. IL-6, and IL-10. Macrophages cultured in
concentrations of echinacea as low, as 0.012 g/ml produced
significantly higher levels of IL-1, TNF-x, IL-6 and IL-10 (P <
0.05) than unstimulated cells. The high levels of IL-1, TNF-x,
and IL-10 induced by very low levels of echinacea are consistent
with an immune activated antiviral effect. Echinacea induced
loweer levels of IL-6 in comparison to the other cytokines
measured. These results demonstrate the immune stimulatorv
ability of the unpurified fresh pressed juice of Echinacea
purpurea and offer some insight into the nature of the resulting,
immune response as compared to endotoxin.